A Closer Look at Access to Essential Medicines in South Sudan

By Staff Writer

January 7, 2024

The Crucial Role of Medicines in Healthcare

When it comes to medical care and access to essential medicines in South Sudan, medicines are an essential component. Essential medicines play a crucial role in reducing morbidity and mortality rates from acute and chronic diseases. Meeting the United Nations’ Sustainable Development Goals (SDGs) requires comprehensive research and policy implementation to ensure easy access to these medicines. A global commitment is necessary to address gaps in healthcare access and pharmaceutical supply chains. This commitment will support the World Health Organization’s goal of achieving 80% availability by 2025. A human right is the right to have access to medications that are safe, effective, of high quality, and inexpensive. The reality, however, is very different from this ideal in many low- and middle-income countries (LMICs), where access to medicines is frequently hindered by issues such as a lack of availability and an unaffordable price.

The Status Quo in South Sudan

Despite its efforts to boost its healthcare system since gaining independence, South Sudan faces numerous issues. Protracted violence, poverty, inefficient pharmaceutical supply management, an inadequately skilled workforce, lack of infrastructure, and climate change effects impede progress. The country has set up the Emergency Medications Fund (EMF) to improve the provision of essential drugs and high-quality medical services. The South Sudan Ministry of Health and other organisations collaborated to develop this fund. But difficulties still exist, particularly with regard to gaining access to essential medicines in South Sudan.

Investigating Medicine Prices, Availability, and Affordability

Researchers conducted a study in Juba County, South Sudan, to determine the pricing, availability, and affordability of essential drugs. They aimed to gauge the progress of the nation in enhancing the accessibility and affordability of its medical facilities. The study revealed inadequate availability of pharmaceuticals across all investigated sectors. The public sector showed an average availability of only 50.4%. The study found only 0.07% of the examined drugs affordable, declaring the majority as unaffordable due to high pricing.

Perspectives on the Future and Recommendations

The findings of the study on access to essential medicines in South Sudan led to the formulation of a number of conclusions and suggestions. Among these are the implementation of regulations that regulate prices, particularly in the private sector, the enhancement of funds for the health sector, and the expansion of the availability of medicines in the public sector. These findings can serve as substantial evidence for policymakers to use when formulating policies that will limit prices, boost the supply of medicines and make them more affordable, strengthen the public health system, and reorganise the pharmaceutical sector in South Sudan.

Reference url

Recent Posts

implantable glucose device
         

T1 Diabetes Care with an Implantable Glucose Device

🚀 Are we on the brink of a diabetes breakthrough?

A newly developed implantable glucose device from MIT could revolutionize diabetes management, providing an autonomous solution to prevent life-threatening hypoglycemic episodes. This innovative device combines continuous glucose monitoring with responsive hormone delivery, potentially transforming patient care by reducing the need for constant oversight.

Curious about how this technology could reshape diabetes outcomes and healthcare economics? Dive into the full article for a closer look!

#SyenzaNews #HealthTech #HealthEconomics #Innovation

federated learning governance
      

Federated Learning Governance in Healthcare: A Framework for Ethical and Effective Implementation

🔍 Have you considered how federated learning governance can revolutionize healthcare data collaboration?

In our latest article, we explore the critical principles of federated learning governance, emphasizing its role in managing decentralized health data while protecting patient privacy and improving research quality. Learn about the actionable strategies healthcare organizations can implement to navigate the unique challenges that come with this innovative approach.

Dive deeper into the world of federated learning in healthcare and unlock its potential for ethical and effective data use!

#SyenzaNews #AIinHealthcare #DigitalHealth

Cecolin 9 HPV vaccine
        

Cecolin 9 HPV Vaccine: A Game Changer for Cervical Cancer Prevention in China

🌍 Did you know that China has just achieved a historic milestone in the fight against cervical cancer?

The approval of the Cecolin 9 HPV vaccine, the first domestically developed 9-valent HPV vaccine, marks a transformative moment for public health, enhancing access and affordability across the nation. This development not only meets global health goals but also reshapes the landscape of cervical cancer prevention in China.

Curious to learn how this advancement is set to impact vaccination efforts and healthcare economics? Dive into the full article for deeper insights!

#SyenzaNews #globalhealth #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.